黑料网

Immunology: Current Research
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Immunol Curr Res 2023, Vol 7(3): 139
  • DOI: 10.4172/icr.1000139

Immunotherapy System in Cancer Treatment

Dr. Omar Shattuck*
Department of Nephrology, Provincial Hospital, Affiliated to Shandong University, Jinan, 250021, Shandong, China
*Corresponding Author : Dr. Omar Shattuck, Department of Nephrology, Provincial Hospital, Affiliated to Shandong University, Jinan, 250021, Shandong, China, Email: shattuck@gmail.com

Received Date: May 01, 2023 / Accepted Date: May 28, 2023 / Published Date: May 29, 2023

Abstract

Immunotherapy has revolutionized the landscape of cancer treatment, offering new hope and opportunities for patients battling various types of cancer. Unlike traditional treatment modalities such as surgery, chemotherapy, and radiation therapy, which directly target cancer cells, immunotherapy works by stimulating the body's immune system to recognize and attack cancer cells. This article explores the concept of immunotherapy, its mechanisms, different approaches, and its remarkable impact on cancer treatment. Immunotherapy has emerged as a groundbreaking approach in cancer treatment, offering new avenues for patients battling various malignancies. Unlike traditional therapies that directly target cancer cells, immunotherapy harnesses the power of the immune system to recognize and eliminate cancer cells. This abstract provides a concise overview of the principles, mechanisms, and clinical impact of immunotherapy. Immunotherapy utilizes different strategies to enhance the immune response against cancer. Checkpoint inhibitors, such as PD-1 and CTLA-4 inhibitors, release the brakes on the immune system,enabling it to effectively recognize and destroy cancer cells. CAR-T cell therapy genetically modifies a patient's T cells to target specific cancer cells, while immune-modulating antibodies directly target cancer cells or stimulate immune responses. Cancer vaccines and adoptive cell transfer further bolster the immune system's ability to combat cancer.The impact of immunotherapy in cancer treatment has been remarkable. It has revolutionized the management of various malignancies, leading to durable responses and long-term remission in patients. Immunotherapy has shown particular success in metastatic melanoma, lung cancer, and kidney cancer. Ongoing research aims to expand the application of immunotherapy to other cancer types and improve treatment outcomes.

Citation: Shattuck O (2023) Immunotherapy System in Cancer Treatment.Immunol Curr Res, 7: 139. Doi: 10.4172/icr.1000139

Copyright: © 2023 Shattuck O. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top